Evidence map›Paper›PMID 34288579›Full record

ArticleMolecular genetics & genomic medicine2021

Mosaic proximal trisomy 13q and regular trisomy 13 in a female patient with long survival: Involvement of an incomplete trisomic rescue and a chromothripsis event.

Verónica Fabiola Morán-Barroso, Alicia Cervantes, María Del Refugio Rivera-Vega, Adriana Del Castillo-Moreno, Alejandra Moreno-Chacón, Estefanía Mejía-Cauich, Laura Eréndira Contreras-Ortiz, Fernando Fernández-Ramírez

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Chromothripsis.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Verónica Fabiola Morán-BarrosoServicio de Genética, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México.ORCID 0000-0002-3768-9687
Alicia CervantesServicio de Genética, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México.ORCID 0000-0002-7459-8047
María Del Refugio Rivera-VegaServicio de Genética, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México.
Adriana Del Castillo-MorenoServicio de Genética, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México.ORCID 0000-0002-1154-5714
Alejandra Moreno-ChacónServicio de Genética, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México.
Estefanía Mejía-CauichFacultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, México.ORCID 0000-0003-1563-3612
Laura Eréndira Contreras-OrtizServicio de Genética, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México.ORCID 0000-0002-2097-801X
Fernando Fernández-RamírezServicio de Genética, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México.ORCID 0000-0002-7016-1948
Hospital General de México · MXUniversidad Autónoma de la Ciudad de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTrisomy 13 or Patau syndrome has a prevalence of 1:10,000-20,000 and is characterized by microcephaly, microphthalmia, polydactyly, as well as other dysmorphic features and malformations, with a patient survival of 13% in the first year. Trisomy 13 presents either as a free chromosome 13 trisomy or associated with a chromosomal Robertsonian translocation, as partial trisomy affecting proximal or distal 13q regions, and also as a mosaic. Mosaic trisomy 13 shows a highly variable phenotype, displaying from mild to severe affectations. We present a 12-year-old Mexican female patient with intellectual disability, dysmorphic features, polymenorrhea, and long survival, whose initial cytogenetic study referred to a small supernumerary marker chromosome.

methodsGTG banding karyotype, high-resolution chromosomal microarray, and fluorescent in situ hybridization analyses were performed in peripheral blood cells.

resultsOur analyses demonstrated a de novo mosaicism in our patient, constituted by proximal trisomy 13q10-q14.3 (82%) and free trisomy 13 (18%) cell lines. Her final chromosomal complement is mos 47,XX,+del(13)(q14.3)[25]/47,XX,+13[7].ish del(13)(RB1+)[17]/13q14(RB1x3)[2].arr[GRCh37] 13q11q14.3(19436286_51726415)x3,13q11q34(19436286_115107733)x2-3 dn.

conclusionsThe wide spectrum of clinical manifestations observed in our patient mainly results from the proximal trisomy 13q, and her phenotype is modified by the presence of a free trisomy 13 cell line. We propose that her mosaicism probably derived from a trisomic zygote that underwent a failed trisomic rescue associated with chromothripsis, originating the cell line with partial 13q proximal trisomy, whose selective advantage could explain the long survival of our patient.

Indexed as

ChromothripsisCells, CulturedChildFemaleHumansPhenotypeTrisomy 13 Syndromechromothripsishyperpolymenorrheamosaic trisomy 13proximal trisomy 13qtrisomic rescue

Identifiers

PMID34288579
PMCPMC8457692
OpenAlexW3186928040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.